A dream:
A recommendation to not transfuse FFP or platelets before routine procedures in #cirrhosis (including para, thora, and banding) that is co-signed by societies representing gastroenterology, radiology, anesthesiology, and pathology
With me?
It takes a village
How pharmacists can help identify and resolve potentially serious medication-related problems in #cirrhosis
Openaccess: https://t.co/UCeZRr6NyD. With Editorial by Aye & Volk
Glad I work with THE @DrDrugExpert !
What are the Immune Determinants in the Hepatitis B vaccination series for adults? Read here to find out more! https://t.co/6nuPyw8adf @GSzaboMD@AdamMikMD#VisualAbstract
From @HEP_Journal: "Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma" https://t.co/6DtRTcp6bj #AASLDjournals#HCC
Start of the Dallas Fort Worth American Liver Foundation Debates! Teams from UT Southwestern, Methodist Dallas, Baylor College of Medicine, and Oklahoma Health Sciences Center. Packed room, standing room only! Game on! @ALF_Texas@UTSWNews@bcmhouston@arjimufti@jmarrero6713
Our EVEndo score is now available on MDCalc! A score for adult patients with cirrhosis to non-invasively predict the presence and size of esophageal varices on screening endoscopy! Check it out https://t.co/q00trtjzpy ; The CGH paper https://t.co/c9ccfEEpx2 @AASLDtweets@AGA_CGH
"What we aren't eating is killing us," global study finds @CNN https://t.co/w2gKuBo8NG. Impactful piece on how certain aspects of our diet accounted for 50% of global death and 2/3 of years lost to disability.
Readmissions after liver transplant and the role of the APP
https://t.co/XUmsae15IL
👉readmits after OLT r crazy high
👉APP may ⬇️risk
👉❤️that outpt APP met pt b4 d/c